« Back
Home /
Polmacoxib

Polmacoxib

Item no.	TMO-T21294-25mg
Manufacturer	TargetMol
CASRN	301692-76-2
Amount	25mg
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Smiles	CC1(C(=O)C(=C(O1)C2=CC=C(C=C2)S(=O)(=O)N)C3=CC(=CC=C3)F)C
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	Carbonic Anhydrase,COX,COX, CG100649 , CG 100649 , CG-100649
Available
Short Description	Polmacoxib is a first-in-class NSAID drug candidate, is a dual inhibitor of carbonic anhydrase (CA) and COX-2. Polmacoxib inhibits premalignant and malignant colorectal lesions in mouse models, partly through inhibiting tumor cell proliferation.
Shipping	cool pack
Storage	-20°
Target names or alias	CG100649 , CG 100649 , CG-100649
Molecular Weight	361, 39
Pathway	Immunology/Inflammation\|\|\|Neuroscience\|\|\|Metabolism
Target	COX\|\|\|Carbonic Anhydrase

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 25mg

available

Delivery expected until 9/27/2024

Express Delivery: Save 4 days

Compare

Add to wishlist

Recommend by mail